Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,704 USD | -3,25% | -2,75% | +11,72% |
Attività
Numero di dipendenti: 2
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joseph Lawler
FOU | Founder | 52 | 23/04/20 |
Chief Executive Officer | 54 | 05/10/23 | |
Daniel George
DFI | Director of Finance/CFO | 54 | 28/09/23 |
Kenneth Cundy
CTO | Chief Tech/Sci/R&D Officer | 65 | 20/05/22 |
Madison Damour
IRC | Investor Relations Contact | - | - |
Scott Anderson
IRC | Investor Relations Contact | - | 06/01/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jason Aryeh
BRD | Director/Board Member | 56 | 01/03/21 |
Kenneth Lin
BRD | Director/Board Member | 51 | 01/02/21 |
Bimal Shah
BRD | Director/Board Member | 48 | 05/10/23 |
Chief Executive Officer | 54 | 05/10/23 | |
Director/Board Member | 42 | 01/11/22 | |
Karah Parschauer
BRD | Director/Board Member | 46 | 01/02/21 |
Joseph Lawler
FOU | Founder | 52 | 23/04/20 |
Aron English
BRD | Director/Board Member | 41 | 01/06/20 |
Areta Kupchyk
BRD | Director/Board Member | 67 | 01/04/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 25 933 217 | 8 978 689 ( 34,62 %) | 0 | 34,62 % |
Coordinate società
Anebulo Pharmaceuticals, Inc.
1017 Ranch Road 620 South Suite 107
78734, Lakeway
+(512) 598-0931
http://www.anebulo.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+11,72% | 70,11 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione ANEB
- Società Anebulo Pharmaceuticals, Inc.